Project Grant K01DK141969

Award Date 1/1/25
Completion Date 11/30/27
Dollars Obligated $152K
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Boston, MA 02215, USA
Similar Awards
This $681,144.00 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research on the role of biomechanical interfaces created by focal adhesion kinase in catecholamine signaling. The award, with a performance period from September 10, 2024 to June 30, 2028, will fund pioneering work by a multi-principal investigator team to establish...
This federal Project Grant award, with ID R01DK137913, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The $538,357 grant, awarded on Sep 10, 2024, supports research to define the molecular regulation and physiological role of a novel lysosomal mechanism of adipocyte lipolysis. The project aims to leverage innovative methods, including in vivo studies,...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support a research project to investigate the effects of dietary fat and carbohydrate composition on energy metabolism and obesity. The $506,598 award, effective from September 15, 2024 to August 31, 2025, will leverage expertise in "fluxomics" to quantify metabolic...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $604,853 Project Grant to Rockefeller University under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, which runs from September 1, 2024 to August 31, 2025, will fund a research project to elucidate the genetic determinants of human brown adipose tissue (BAT) function. The project employs innovative strategies to leverage data from unique human cohorts to...
This $659,199 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research on the biology and therapeutic potential of the growth differentiation factor 15 (GDF15) signaling pathway. The University of Pittsburgh, the primary awardee, will investigate novel mechanisms by which hepatocyte-derived GDF15 can improve obesity-associated insulin...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $241,500.00 to Duke University to conduct research on the regulation of metabolic diseases by the commensal bacterium Clostridium immunis. The research aims to determine the mechanism by which a polysaccharide secreted by C. immunis decreases visceral adiposity, a key risk factor for...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $171,134 to investigate how pro-inflammatory cytokines impact the structure and function of the Golgi apparatus in pancreatic beta cells. The research aims to understand the role of the GRASP55 protein in mediating cytokine-induced Golgi remodeling and its implications for...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $665,717 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Beth Israel Deaconess Medical Center, Inc. (Bidmc) to investigate the biochemical and functional role of N-acyl amino acids, an emerging class of lipid signaling molecules, in human metabolism. The research aims to characterize N-acyl amino acids as substrates and competitive inhibitors of...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $1,539,044 to New York University School of Medicine to investigate the effects of obesity and diabetes on pulmonary and extra-pulmonary immune responses to respiratory viral infections, such as SARS-CoV-2 and influenza. The research aims to elucidate how hyperglycemia and obesity...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research program provides $800,000.00 to the Icahn School of Medicine at Mount Sinai to conduct research on the role of the mammary gland's secretome in inter-organ communication and its impact on obesity and type 2 diabetes. The research aims to identify novel "mammokines" - signaling molecules from...

This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under CFDA Program 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research will provide $152,454 to the Dana-Farber Cancer Institute, Inc. (DFCI) to conduct a mechanistic study on the role of the protein irisin in regulating immune response and adipose tissue dynamics. The key objectives are to: (1) investigate the molecular mechanisms by which irisin interacts with integrin receptors to modulate adipose inflammation, (2) dissect the downstream immune response pathways that are regulated by irisin, and (3) identify other irisin-like hormone molecules that may have protective effects against metabolic diseases like diabetes. This research is expected to contribute to fundamental knowledge of integrin biology as well as the development of new therapeutic approaches for treating obesity, diabetes, and associated conditions. The award period is from January 1, 2025 to November 30, 2027.

Generated 4/8/25, 5:35 AM